Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Ponikowski, Piotr ; Ohlsson, Marcus LU orcid and Jankowska, Ewa A. (2020) In The Lancet 396(10200). p.1895-1904
Abstract
Background: Intravenous ferric carboxymaltose has been shown to improve symptoms and quality of life in patients with chronic heart failure and iron deficiency. We aimed to evaluate the effect of ferric carboxymaltose, compared with placebo, on outcomes in patients who were stabilised after an episode of acute heart failure. Methods: AFFIRM-AHF was a multicentre, double-blind, randomised trial done at 121 sites in Europe, South America, and Singapore. Eligible patients were aged 18 years or older, were hospitalised for acute heart failure with concomitant iron deficiency (defined as ferritin
Please use this url to cite or link to this publication:
author
; and
author collaboration
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
The Lancet
volume
396
issue
10200
pages
1895 - 1904
publisher
Elsevier
external identifiers
  • scopus:85096879690
ISSN
0140-6736
DOI
10.1016/S0140-6736(20)32339-4
language
English
LU publication?
yes
id
a5b7f1a2-61f7-4ad9-bd75-3f639cf89a16
date added to LUP
2020-12-14 13:27:02
date last changed
2025-04-04 14:03:24
@article{a5b7f1a2-61f7-4ad9-bd75-3f639cf89a16,
  abstract     = {{Background: Intravenous ferric carboxymaltose has been shown to improve symptoms and quality of life in patients with chronic heart failure and iron deficiency. We aimed to evaluate the effect of ferric carboxymaltose, compared with placebo, on outcomes in patients who were stabilised after an episode of acute heart failure. Methods: AFFIRM-AHF was a multicentre, double-blind, randomised trial done at 121 sites in Europe, South America, and Singapore. Eligible patients were aged 18 years or older, were hospitalised for acute heart failure with concomitant iron deficiency (defined as ferritin}},
  author       = {{Ponikowski, Piotr and Ohlsson, Marcus and Jankowska, Ewa A.}},
  issn         = {{0140-6736}},
  language     = {{eng}},
  number       = {{10200}},
  pages        = {{1895--1904}},
  publisher    = {{Elsevier}},
  series       = {{The Lancet}},
  title        = {{Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial}},
  url          = {{http://dx.doi.org/10.1016/S0140-6736(20)32339-4}},
  doi          = {{10.1016/S0140-6736(20)32339-4}},
  volume       = {{396}},
  year         = {{2020}},
}